1-20 of 69
Authors: Marta M Alonso
Journal Article
TMOD-07. DEVELOPMENT AND CHARACTERIZATION OF A SPINAL CORD DIFFUSE MIDLINE GLIOMA MODEL Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii320, https://doi.org/10.1093/neuonc/noae165.1271
Published: 11 November 2024
Journal Article
IMMU-48. CRACKING THE ROLE OF ONCOMETABOLITES IN VIROIMMUNOTHERAPY FOR PEDIATRIC MALIGNANT BRAIN TUMORS Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii163, https://doi.org/10.1093/neuonc/noae165.0641
Published: 11 November 2024
Journal Article
The emerging field of viroimmunotherapy for pediatric brain tumors Get access
Neuro-Oncology, Volume 26, Issue 11, November 2024, Pages 1981–1993, https://doi.org/10.1093/neuonc/noae160
Published: 16 August 2024
Journal Article
DIPG-36. DRD2 ANTAGONISM RESCUES IMMUNE-TUMOR SURVEILLANCE, WARMING THE TUMOR IMMUNE MICROENVIRONMENT OF DIFFUSE MIDLINE GLIOMA MODELS Open Access
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.089
Published: 18 June 2024
Journal Article
ETMR-10. DEVELOPMENT AND CHARACTERIZATION OF A NOVEL IMMUNOCOMPETENT ORTHOTOPIC MOUSE MODEL FOR THE STUDY OF EMBRYONAL TUMORS WITH MULTILAYERED ROSETTES (ETMRS) Open Access
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.180
Published: 18 June 2024
Journal Article
DIPG-45. TARGETING HYPERACETYLATION IN PEDIATRIC DIFFUSE MIDLINE GLIOMAS USING ONCOLYTIC ADENOVIRUSES Open Access
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.098
Published: 18 June 2024
Journal Article
DIPG-13. TIM-3 TARGETED APTAMER IN COMBINATION WITH LOCO-REGIONAL RADIOTHERAPY IMPROVES SURVIVAL BY MODULATING THE IMMUNE INFILTRATION IN DIFFUSE MIDLINE GLIOMA MODELS Open Access
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.066
Published: 18 June 2024
Journal Article
HGG-18. ONC201 COMBINED WITH THE ONCOLYTIC ADENOVIRUS DELTA-24-RGD AS A NEW THERAPEUTIC REGIME FOR PEDIATRIC HIGH-GRADE AND DIFFUSE MIDLINE GLIOMAS Open Access
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.302
Published: 18 June 2024
Journal Article
Gliomatosis cerebri in children: A poor prognostic phenotype of diffuse gliomas with a distinct molecular profile Open Access
Neuro-Oncology, Volume 26, Issue 9, September 2024, Pages 1723–1737, https://doi.org/10.1093/neuonc/noae080
Published: 08 May 2024
Journal Article
The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models Open Access
Neuro-Oncology, Volume 26, Issue 8, August 2024, Pages 1509–1525, https://doi.org/10.1093/neuonc/noae066
Published: 30 March 2024
Journal Article
DIPG-04. TUMOR CELL-INTRINSIC TIM-3 PROMOTES DIFFUSE INTRINSIC PONTINE GLIOMA TUMORIGENESIS Open Access
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Page i13, https://doi.org/10.1093/neuonc/noad073.051
Published: 12 June 2023
Journal Article
HGG-09. GLIOMATOSIS CEREBRI IN CHILDREN: A POOR PROGNOSTIC, HIGHLY INFILTRATIVE PHENOTYPE OF DIFFUSE PEDIATRIC HIGH-GRADE GLIOMAS WITH DISTINCT MOLECULAR FEATURES Open Access
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Pages i40–i41, https://doi.org/10.1093/neuonc/noad073.158
Published: 12 June 2023
Journal Article
DIPG-22. TRIPTOLIDE AS A POTENTIALLY PROMISING THERAPY FOR DIFFUSE MIDLINE GLIOMA Open Access
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Page i17, https://doi.org/10.1093/neuonc/noad073.069
Published: 12 June 2023
Journal Article
IMMU-39. NANOPARTICLE TREATMENT REBALANCES IMMUNODOMINANCE OF ANTI-VIRUS IMMUNITY TO ENHANCE ANTI-TUMOR IMMUNITY DURING ONCOLYTIC ADENOVIRUS THERAPY IN SOLID TUMORS Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii139–vii140, https://doi.org/10.1093/neuonc/noac209.536
Published: 14 November 2022
Journal Article
EXTH-94. LOCALIZED INTRATUMORAL TREATMENT WITH ADOPTIVE T CELL THERAPY FOLLOWED BY ONCOLYTIC ADENOVIRUS DELTA-24-RGDOX INDUCES SUSTAINABLE REGRESSION OF DISSEMINATED SOLID TUMORS THROUGH ANTIGEN SPREAD Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii231, https://doi.org/10.1093/neuonc/noac209.892
Published: 14 November 2022
Journal Article
TMIC-06. ANTAGONISM OF DRD2 USING ONC201 INCREASED EXPRESSION OF ANTIGEN PRESENTATION PATHWAY PROTEINS IN DIFFUSE MIDLINE GLIOMA, RECRUITING TUMOR INFILTRATING LYMPHOCYTES IN VIVO Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii272, https://doi.org/10.1093/neuonc/noac209.1050
Published: 14 November 2022
Journal Article
EXTH-62. EXAMINATION OF THE TUMOR MICROENVIRONMENT OF GLIOMAS TREATED WITH VIROIMMUNOTHERAPY REVEALS THE PRODUCTION OF ONCOMETABOLITES LEADING TO IMPROVED THERAPEUTIC STRATEGIES Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii223, https://doi.org/10.1093/neuonc/noac209.860
Published: 14 November 2022
Journal Article
IMMU-11. NONO IS A NEW ADENOVIRUS SENSOR: IMPLICATION FOR VIROTHERAPY Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii133, https://doi.org/10.1093/neuonc/noac209.509
Published: 14 November 2022
Journal Article
EXTH-58. UNRAVELING THE MECHANISMS UNDERLYING THE THERAPEUTIC EFFICACY OF TIM-3 BLOCKADE IN DIPGS Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii222, https://doi.org/10.1093/neuonc/noac209.856
Published: 14 November 2022
Journal Article
DIPG-22. Modifying the tumor microenvironment with a TIM-3 monoclonal antibody as a therapeutic strategy for DIPGs Open Access
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Pages i22–i23, https://doi.org/10.1093/neuonc/noac079.079
Published: 03 June 2022
